UBS Group »

Novabay Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Novabay Pharmaceuticals (NBY) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Novabay Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Novabay Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novabay Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.7k 8.5k 0.20
2023-09-30 $112 249 0.45
2023-03-31 $308 182 1.70
2022-12-31 $9.6k 4.9k 1.95